JARI KELLOKOSKI

Yhteystiedot

Julkaisut

• Hallikainen, Joona; Seppa, Juha; Kellokoski, Jari. 2021. Novel maxillary enlargement technique in congenital nasal pyriform aperture stenosis: a case report and literature review BMJ case reports 14 5: e240149. 2021
• Kämäräinen, Minna; Savolainen, Jarno; Tynkkynen, Jenni; Kellokoski, Jari; Pahkala, Riitta. 2021. Long-term patient satisfaction and the sense of coherence - a longitudinal study 10-15 years after orthognathic surgery Acta odontologica scandinavica [Epub ahead of print 11 Jan 2021]: 1-10. 2021
• Hallikainen, J; Keränen, S; Savolainen, J; Närhi, M; Suominen, AL; Ylöstalo, P; Kellokoski, J; Pyysalo, M; Pussinen, P; Rauramaa, T; Frösen, J. 2020. Role of oral pathogens in the pathogenesis of intracranial aneurysm: review of existing evidence and potential mechanisms Neurosurgical review 2021; 44: 239-247. 2020
• Nykänen, Jonni; Pajunen, Jenna; Ikävalko, Tiina; Savolainen, Jarno; Kellokoski, Jari. 2020. Surgery First Approach ortognaattisessa hoidossa Suomen hammaslääkärilehti 27 13: 26 - 31. 2020
• Thorén, Hanna; Pöllänen, Marja; Kellokoski, Jari; Palotie, Tuula; Sipola, Annina; Snäll, Johanna; Välimaa, Hanna. 2020. Viisaudenhammas Suomen hammaslääkärilehti 27 6: 30-42. 2020
• Hallikainen, J; Lindgren, A; Savolainen, J; Selander, T; Jula, A; Närhi, M; Koivisto, T; Kellokoski, J; Ylöstalo, P; Suominen, AL; Frösen, J. 2019. Periodontitis and gingival bleeding associate with intracranial aneurysms and risk of aneurysmal subarachnoid hemorrhage Neurosurgical review 2020; 43: 669-679. 2019
• Kemppainen, Siiri; Ikävalko, Tiina; Kellokoski, Jari; Seppä, Juha; Savolainen, Jarno. 2019. Ortognaattinen hoito obstruktiivisen uniapnean hoitovaihtoehtona Duodecim 135 3: 289-295. 2019
• Riepponen A, Myllykangas R, Savolainen J, Kilpeläinen P, Kellokoski J, Pahkala R. 2016. Changes in posterior airway space and hyoid bone position after surgical mandibular advancement. ACTA ODONTOLOGICA SCANDINAVICA 2017; 75 1: 73-78. 2016
• Vierola Anu, Suominen Anna Liisa, Lindi Virpi, Viitasalo Anna, Ikävalko Tiina, Lintu Niina, Väistö Juuso, Kellokoski Jari, Närhi Matti, Lakka Timo A. 2016. Associations of Sedentary Behavior, Physical Activity, Cardiorespiratory Fitness, and Body Fat Content With Pain Conditions in Children: The Physical Activity and Nutrition in Children Study. JOURNAL OF PAIN 17 7: 845-853. 2016
• Kurppa Kari J, Catón Javier, Morgan Peter R, Ristimäki Ari, Ruhin Blandine, Kellokoski Jari, Elenius Klaus, Heikinheimo Kristiina. 2014. High frequency of BRAF V600E mutations in ameloblastoma. The Journal of Pathology 232 5: 492-498. 2014
• Savolainen JJ, Kellokoski JK. 2012. Ganglion cyst of the temporomandibular joint. Oral & Maxillofacial Surgery -: -. 2012
• Vierola A, Suominen AL, Ikävalko T, Lintu N, Lindi V, Lakka H-M, Kellokoski J, Närhi M, Lakka TA. 2012. Clinical signs of temporomandibular disorders and various pain conditions among children 6 to 8 years of age: The Panic Study JOURNAL OF OROFACIAL PAIN 26 1: 17-25. 2012
• Kosunen A, Pirinen R, Ropponen K, Pukkila M, Kellokoski J, Virtaniemi J, Sironen R, Juhola M, Kumpulainen E, Johansson R, Nuutinen J, Kosma V-M. 2007. CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma ORAL ONCOLOGY 43: 51-59. 2007
• Pahkala RH, Kellokoski JK. 2007. Surgical-orthodontic treatment and patients' functional and psychosocial weel-being. AMERICAN JOURNAL OF ORTHODONTICS AND DENTOFACIAL ORTHOPEDICS 132: 158-164. 2007
• Pukkila M, Kosunen A, Ropponen K, Virtaniemi J, Kellokoski J, Kumpulainen E, Pirinen R, Nuutinen J, Johansson R, Kosma V-M. 2007. High stromal versican expression predicts unfavourable outcome in oral squamous cell carcinoma. JOURNAL OF CLINICAL PATHOLOGY 60: 267-272. 2007
• Puranen MH, Ropponen KM, Kellokoski JK. 2006. Myeloid sarcoma: Case report with an unusual presentation in radicular cyst capsule. ORAL ONCOLOGY EXTRA 42: 190-193. 2006
• Pellikainen JM, Ropponen KM, Kataja VV, Kellokoski JK, Eskelinen MJ, Kosma V-M. 2004. Expression of matrix metalloproteinase (MMP)-2 and MMP-2 in breast cancer with a special reference to activator protein-2, HER2, and prognosis. CLINICAL CANCER RESEARCH 10: 7621-7628. 2004
• Pukkila MJ, Kosunen AST, Virtaniemi JA, Kumpulainen EJ, Johansson RT, Kellokoski JK, Nuutinen J, Kosma V-M. 2004. Versican expression in pharyngeal squamous cell carcinoma: an immunohistochemical study JOURNAL OF CLINICAL PATHOLOGY 57: 735-739. 2004
• Pellikainen J, Naukkarinen A, Ropponen K, Rummukainen J, Kataja V, Kellokoski J, Eskelinen M, Kosma V-M. 2004. Expression of HER2 and its association with AP-2 in breast cancer EUROPEAN JOURNAL OF CANCER 40: 1485-1495. 2004
• Kosunen A, Ropponen K, Kellokoski J, Pukkila M, Virtaniemi J, Valtonen H, Kumpulainen E, Johansson R, Tammi R, Tammi M, Nuutinen J, Kosma V-M. 2004. Reduced expression of hyaluronan is a strong indicator of poor survival in oral squamous cell carcinoma ORAL ONCOLOGY 40: 257-263. 2004
• Pellikainen MJ, Pekola TT, Ropponen KM, Kataja VV, Kellokoski JK, Eskelinen MJ, Kosma V-M. 2003. p21WAF1 expression in invasive breast cancer and its association with p53, AP-2, cell proliferation, and prognosis JOURNAL OF CLINICAL PATHOLOGY 56: 214-220. 2003
• Kellokoski J, Lamberg M. 2002. Kasvomurtumapotilas toipuu uusilla tekniikoilla entistä nopeammin. PINSETTI 1: 8-9. 2002
• Pellikainen J, Kataja V, Ropponen K, Kellokoski J, Pietiläinen T, Böhm J, Eskelinen M, Kosma V-M. 2002. Reduced nuclear expression of transcription factor AP-2 associates with aggressive breast cancer. CLINICAL CANCER RESEARCH 8: 3487-3495. 2002
• Pukkila MJ, Kellokoski JK, Virtaniemi JA, Kumpulainen EJ, Johansson RT, Halonen PM, Kosunen AST, Nuutinen J, Kosma V-M. 2002. Inducible nitric oxide synthase expression in pharyngeal squamous cell carcinoma: Relation to p53 expression, clinicopathological data, and survival. LARYNGOSCOPE 112: 1084-1088. 2002
• Pukkila MJ, Kumpulainen EJ, Virtaniemi JA, Johansson RT, Halonen PM, Kellokoski JK, Kosunen AST, Nuutinen J, Kosma V-M. 2002. Nuclear and cytoplasmic p53 expression in pharyngeal squamous cell carcinoma: prognostic implications. HEAD AND NECK (NEW YORK NY) 24 8: 784-791. 2002
• Ropponen KM, Kellokoski JK, Lipponen PK, Eskelinen MJ, Alanne L, Alhava EM, Kosma V-M. 2000. Expression of inducible nitric oxide synthase in colorectal cancer and its association with prognosis SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 35: 1204-1211. 2000
• Pirinen R, Hirvikoski P, Böhm J, Kellokoski J, Moisio K, Virén M, Johansson R, Hollmén S, Kosma V-M. 2000. Reduced expression of CD44v3 variant isoform is associated with unfavorable outcome in non-small cell lung carcinoma. HUMAN PATHOLOGY (PHILADELPHIA PA) 31: 1088-1095. 2000
• Lipponen P, Aaltomaa S, Kellokoski J, Ala-Opas M, Kosma V-M. 2000. Expression of activator protein 2 in prostate cancer is related to tumor differentiation and cell proliferation. EUROPEAN UROLOGY 37: 573-578. 2000
• Karjalainen JM, Kellokoski JK, Mannermaa AJ, Kujala HE, Moisio KI, Mitchell PJ, Eskelinen MJ, Alhava EM, Kosma VM. 2000. Failure in post-transcriptional processing is a possible inactivation mechanism of AP-2 alfa in cutaneous melanoma BRITISH JOURNAL OF CANCER 82 12: 2015-2021. 2000
• Böhm JP, Niskanen LK, Pirinen RT, Kiraly K, Kellokoski JK, Moisio KI, Eskelinen MJ, Tulla HE, Hollmen S, Alhava EM, Kosma V-M. 2000. Reduced CD44 standard expression is associated with tumour recurrence and unfavourable outcome in differentiated thyroid carcinoma JOURNAL OF PATHOLOGY 192: 321-327. 2000
• Böhm J, Niskanen L, Kiraly K, Kellokoski J, Eskelinen M, Hollmen S, Alhava E, Kosma V-M. 2000. Expression and prognostic value of alfa-, beta- and gamma-catenins in differentiated thyroid carcinoma. JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 85 12: 4806-4811. 2000
• Anttila MA, Kellokoski JK, Moisio KI, Mitchell PJ, Saarikoski S, Syrjänen K, Kosma V-M. 2000. Expression of transcription factor AP-2 alfa predicts survival in epithelial ovarian cancer. BRITISH JOURNAL OF CANCER 82 12: 1974-1983. 2000
• Hirvikoski P, Kellokoski JK, Kumpulainen EJ, Virtaniemi JA, Johansson RT, Kosma V-M. 1999. Downregulation of p21/WAF1 is related to advanced and dedifferentiated laryngeal squamous cell carcinoma JOURNAL OF CLINICAL PATHOLOGY 52 6: 440-444. 1999
• Karjalainen JM, Eskelinen MJ, Kellokoski JK, Reinikainen M, Alhava EM, Kosma V-M. 1999. p21 WAF1/CIP1 expression in stage I cutaneous malignant melanoma: its relationship with p53, cell proliferation and survival. BRITISH JOURNAL OF CANCER 79 5/6: 895-902. 1999
• Ropponen KM, Kellokoski JK, Lipponen PK, Pietiläinen T, Eskelinen MJ, Alhava EM, Kosma V-M. 1999. p21/WAF1 expression in human colorectal carcinoma: association with p53, transcription factor AP-2 and prognosis. BRITISH JOURNAL OF CANCER 81 1: 133-140. 1999
• Karjalainen JM, Kellokoski JK, Eskelinen MJ, Alhava EM, Kosma V-M. 1998. Downregulation of transcription factor AP-2 predicts poor survival in stage I cutaneous malignant melanoma. JOURNAL OF CLINICAL ONCOLOGY 16 11: 3584-3591. 1998
• Hietala KA, Kosma V-M, Syrjänen KJ, Syrjänen SM, Kellokoski JK. 1997. Correlation of MIB-1 antigen expression with transcription factors Skn-1, Oct-1, AP-2, and HPV type in cervical intraepithelial neoplasia. JOURNAL OF PATHOLOGY 183: 305-310. 1997
• Lappalainen K, Miettinen R, Kellokoski J, Jääskeläinen I, Syrjänen S. 1997. Intracellular distribution of oligonucleotides delivered by cationic liposomes: light and electron microscopic study JOURNAL OF HISTOCHEMISTRY AND CYTOCHEMISTRY 45 2: 265-274. 1997